Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry

Key Points

To evaluate the safety and efficacy of Fortelizin in the treatment of acute ischemic stroke during real-world application.
Observational study design using data from the FORPI registry.
Focus on patients receiving Fortelizin as bridging therapy.
Assessment of clinical outcomes related to safety and efficacy.
Fortelizin demonstrated a favorable safety profile.
Efficacy observed in improving outcomes for acute ischemic stroke patients.

Answers are grounded in this paper and cite their sources.

Observational study demonstrates Fortelizin improves outcomes in acute ischemic stroke, indicating potential clinical benefits.

This study demonstrates the safety and efficacy of Fortelizin in bridging therapy of acute ischemic stroke in real-world clinical practice.

No takes yet. Share an insight, caveat, or question.

Shamalov et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share